These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37246409)

  • 1. Hyperoside prevents doxorubicin-induced cardiotoxicity by inhibiting NOXs/ROS/NLRP3 inflammasome signaling pathway.
    Wei S; Ma W; Jiang C; Liu J; Liu J; Zhang B; Li W
    Phytother Res; 2023 Sep; 37(9):4196-4209. PubMed ID: 37246409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
    Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
    Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
    Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
    Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis.
    Zha W; Zhao Q; Xiao Y; Gan Y; Wei J; Yu M; Xu Y; Xu Q; Wu S; Yu W
    Int Immunopharmacol; 2023 Oct; 123():110736. PubMed ID: 37549513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury.
    Cai W; Teng T; Wang X; Li B; Gu X; Zhou Y
    J Toxicol Sci; 2023; 48(8):469-479. PubMed ID: 37532580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperoside alleviates doxorubicin-induced myocardial cells apoptosis by inhibiting the apoptosis signal-regulating kinase 1/p38 pathway.
    Chen L; Qin Z; Ruan ZB
    PeerJ; 2023; 11():e15315. PubMed ID: 37220525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
    Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
    Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
    Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
    Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation.
    Zhang L; Fan C; Jiao HC; Zhang Q; Jiang YH; Cui J; Liu Y; Jiang YH; Zhang J; Yang MQ; Li Y; Xue YT
    Oxid Med Cell Longev; 2022; 2022():1733834. PubMed ID: 35035656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes.
    Hwang S; Kim SH; Yoo KH; Chung MH; Lee JW; Son KH
    BMC Mol Cell Biol; 2022 Dec; 23(1):55. PubMed ID: 36517746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting heat shock protein 47 alleviated doxorubicin-induced cardiotoxicity and remodeling in mice through suppression of the NLRP3 inflammasome.
    Shi W; Chen J; Zhao N; Xing Y; Liu S; Chen M; Fang W; Zhang T; Li L; Zhang H; Zhang M; Zeng X; Chen S; Wang S; Xie S; Deng W
    J Mol Cell Cardiol; 2024 Jan; 186():81-93. PubMed ID: 37995517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy.
    Sun Z; Fang C; Xu S; Wang B; Li D; Liu X; Mi Y; Guo H; Jiang J
    Biochem Pharmacol; 2023 Jan; 207():115354. PubMed ID: 36435202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice.
    Alzokaky AA; Al-Karmalawy AA; Saleh MA; Abdo W; Farage AE; Belal A; Abourehab MAS; Antar SA
    Life Sci; 2023 Mar; 316():121390. PubMed ID: 36649752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of NR4A1 alleviates doxorubicin-induced cardiotoxicity through inhibiting the activation of the NLRP3 inflammasome.
    Hu H; Zhong Z; Meng L; Chen J; Yu Z; Lu K
    Biochem Biophys Res Commun; 2024 Mar; 700():149582. PubMed ID: 38306930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway.
    Hu S; Liu B; Yang M; Mao S; Ju H; Liu Z; Huang M; Wu G
    Food Funct; 2023 Apr; 14(8):3849-3862. PubMed ID: 37013966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin.
    Maayah ZH; Takahara S; Dyck JRB
    Arch Toxicol; 2021 Jan; 95(1):1-9. PubMed ID: 32852568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.
    Liu J; Jin Y; Wang B; Wang Y; Zuo S; Zhang J
    Biochem Biophys Res Commun; 2021 Jul; 561():7-13. PubMed ID: 33992835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine alleviates doxorubicin cardiotoxicity by inhibiting mitochondrial reactive oxygen species generation.
    Yu JL; Jin Y; Cao XY; Gu HH
    Hum Cell; 2020 Jan; 33(1):47-56. PubMed ID: 31643023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol antagonizes doxorubicin‑induced cardiomyocyte senescence by inhibiting TXNIP‑mediated NLRP3 inflammasome activation.
    Huang PP; Fu J; Liu LH; Wu KF; Liu HX; Qi BM; Liu Y; Qi BL
    Int J Mol Med; 2020 Jan; 45(1):186-194. PubMed ID: 31746354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium Attenuates Doxorubicin-Induced Cardiotoxicity Through Nrf2-NLRP3 Pathway.
    Yang HB; Lu ZY; Yuan W; Li WD; Mao S
    Biol Trace Elem Res; 2022 Jun; 200(6):2848-2856. PubMed ID: 34462843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.